A recently published pilot study outlines the ways in which emocha’s video platform can offer both caregivers and patients a unique advantage. “We believe video Directly Observed Therapy offers an alternative that appears to be as effective as an in-person daily visits by health care workers to assure compliance with drug treatment, but also empowers patients to manage their tuberculosis without added stress,” says Dr. Samuel Holzman, a research fellow in the department of infectious diseases at the Johns Hopkins University School of Medicine and the study’s lead author. In achieving 94 percent medication adherence rate among patients using video DOT in addition to flexibility, convenience, an emphasis on patient privacy, and savings of $1,391 per patient over a six-month treatment course, the study confirms that emocha provides public health departments with a customized and effective solution.
